Drug Information: Ocrelizumab is a fully human anti-CD20 monoclonal antibody which in preclinical studies was more powerful than rituximab. It is taken intravenously.
Showing posts with label Ocrelizumab. Show all posts
Showing posts with label Ocrelizumab. Show all posts
Wednesday, January 5, 2011
Subscribe to:
Posts (Atom)